TINLY
Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, rehabilitation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system; and orthopedic implantable devices, and functional food ingredients. Further, the company provides Recopic, a radio-frequency identification technology for inventory management. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | -153.39 | $217.2B | $16.1B |
| 2025 Q3 | -21.82 | $212.6B | $24.8B |
| 2025 Q2 | -285.55 | $211.6B | $9.8B |
| 2025 Q1 | -3.84 | $243.1B | -$25M |
| 2025 Q4 | -117.28 | $249.4B | $13.4B |
| 2024 Q3 | 4.40 | $248.6B | $3.3B |
| 2024 Q2 | -309.49 | $252.2B | $1.5B |
| 2024 Q1 | 15.93 | $255.3B | -$5.8B |